期刊文献+

^(18)氟脱氧葡萄糖代谢功能图像在头颈部肿瘤诊断中的价值及机理研究 被引量:1

Value of ^(18)F-FDG metabolic imaging in diagnosis and treatment of head and neck tumors and its mechanism study
原文传递
导出
摘要 目的研究^(18)氟脱氧葡萄糖(^(18)F-FDG)双探头符合线路显像和同机 CT 融合技术在头颈部肿瘤诊治中的价值及机理。方法用^(18)F-FDG 双探头符合线路显像(DHTC)和同机 CT 融合技术检查25例头颈部肿瘤,并与 CT/MRI 结果相比较。另收集38例[20例术前行单光子发射型计算机断层(SPECT)/CT 检查]耳鼻咽喉科、口腔外科住院的头颈部癌的新鲜组织标本,行逆转录聚合酶链反应(RT-PCR)和免疫组织化学方法检测。结果 SPECT/CT 诊断灵敏度、特异性和准确性分别为100.0%、87.5%、96.0%;CT/MRI 诊断灵敏度、特异性和准确性分别为64.7%、50.0%、60.0%。在同部位 SPECT/CT 与 CT/MRI 解剖显像比较中,对4例颈部转移淋巴结癌的原发灶及4例头颈部肿块的良恶性的判断,解剖显像不能作出正确诊断,而符合线路显像及图像融合均能作出正确判断。RT-PCR 及免疫组织化学结果:葡萄糖转运蛋白-1(Glut-1)、Glut-3基因在头颈部癌中表达明显高于正常组织、癌旁组织(均 P<0.05);Glut-1蛋白在头颈部癌的表达为78.9%,Glut-3蛋白在正常组织、癌旁组织、头颈部癌中均无表达。结论符合线路显像及图像融合可作为对头颈部肿瘤良恶性鉴别及肿瘤临床分期和分级、鉴别肿瘤经手术或放射治疗后复发、不明原发灶肿瘤检出方面的一种前瞻性检查工具;Glut-1、Glut-3异常表达与头颈部癌的葡萄糖吸收增高有关。 Objective To study the value of ^18F-FDG dual-head tomography with coincidence (DHTC) and single photon emission computerized tomography (SPECT)coincidence imaging in diagnosis and treatment of head and neck tumors and mechanism thereof and analyze the value of glucose transporter proteins in the mechanism of increased uptake glucose of head and neck malignant tumor. Methods Twentyfive patients with head and neck tumors were examined by CT or MRI and underwent ^18F-FDG DHTC and coincidence imaging. The results of these 2 different methods were compared. Fresh tissues of 38 patients with malignant tumors of the head-and-neck underwent RT-PCR and immunohistochenmical examinafion. Results The sensitivity, specificity, and accuracy of ^18F-FDG coincidence imaging and registration with integrated CT (SPECT/CT) in diagnosis of the head and neck tumors was 100. 0%, 87.5%, and 96.0% respectively, all significantly higher than those of the anatomical imaging(64.7%, 50. 0%, and 60. 0% respectively, all P 〈 0. 05 ). For the lesions on the same site, SPECT/CT could diagnose exactly the primary tumor site of neck metastasis in four cases and diagnose the malignancy or benignancy of other four cases that anatomical imaging(CT/MRI) could not diagnose exactly. ^18F-FDG coincidence imaging and registration with integrated CT could find extra lesions of tumors. The results of RT- PCR and immunohistochemistry showed that the mRNA expression and protein expression of Glut-1 and Glut- 3 were higher in the head and neck cancer than that in the normal tissue of head and neck or in the adjacent tissue ( all P 〈 0. 05). Conclusion ^18 F-FDG coincidence imaging and registration with integrated CT can be as a prospective tool that can judge the malignancy or benignancy of head and neck tumor, and stage and classify the tumor, and distinguish recurrence or necrosis of tumor after treatment by surgery or radiotherapy, and detect unknown primary tumor. The abnormal expressions of Glut-1 and Glut-3 may be correhtted with the increased uptake of glucose of head and head cancer.
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第2期109-113,共5页 National Medical Journal of China
基金 浙江省卫生厅基金(2005B064)
关键词 发射型计算机体层摄影术 氟脱氯葡萄糖F18 单糖转运蛋白质类 头颈部肿瘤 Tomography, emission-computed Fludeoxyglucose F18 Monosaccbaride transport proteins Head and neck neoplasms
  • 相关文献

参考文献14

  • 1Warburg O,Wind F,Negalein E.The metabolism of tumors in the body.J Physiol,1927,8:519-530.
  • 2Hatanaka M.Transport of sugars in tumor cell membranes.Biochem Biophys Acta,1974,355:77-104.
  • 3Youne M,Brown RW,Stephenson M,et al.Overexpression of Glut-1 and Glut-3 in stage Ⅰ nonsmall cell lung carcinoma is associated with poor surival.Cancer,1997,80:1046-1051.
  • 4Yamamoto T,Seino Y,Fukumoto H,et al.Over-expression of faciliative glucose transporter genes in human cancer.Biochem Biophys Res Commun,1990,170:223-230.
  • 5Hoffmann M,Kletter K,Becherer A,et al.^18F-fluorodeoxyglucose positron emission tomography (^18 F-FDG-PET)for staging and follow-up of marginal zone B-cell lymphoma.Oncology,2003,64:336-340.
  • 6Higashi T,Saga T,Nakamoto Y,et al.Relationship between retention index in dual phase ^18F-FDG-PET,and hexokinase-Ⅱ and glucose transporter-1 expression in pancreatic cancer.J Nucl Med,2002,43:173-180.
  • 7Paul AK,Tatsumi M,Higuchi I,et al.Gamma camera coincidence imaging with[^18 F] fluorodeoxyglucose in the pretreatment evaluation of patients with oesophageal cancer.Nucl Med Commun,2003,24:963-970.
  • 8Lowe VJ,Boyd JH,Dunphy FR,et al.Surveillance for recurrent head and neck cancer using positron emission tomography.J Clin Oncol,2000,18:651-658.
  • 9李林法,朱阳军,赵葵,闻世凤,沈文华,罗旭光,程维荷.^(18)F-FDG符合显像与同机定位CT图像融合对肿瘤诊断的价值[J].浙江医学,2004,26(1):14-16. 被引量:1
  • 10Wahl RL,Quint LE,Greenough RL,et al.Staging non-small cell lung cancer with FDG-PET,CT and fusion images:preliminary prospective valuation.Radiology,1994,191:371.

二级参考文献20

  • 1Kole AC,Nieweg OE,Prium J,et al.Detection of unknown occult primary rumors using positron emission tomography.Cancer, 1998,82 : 1160.
  • 2Bar-Shalom R,Valdivia AY,Blaufox MD.PET imaging in oncology.Semin Nucl Med,2000,30:150.
  • 3Kubota K. Cancer diagnosis with positron emission tomography.Kaku Igaku,1996,33: 207.
  • 4Engel H,Steinert H,Buck A,et al.Whole-body PET:Physiological and artifactual fluorodeoxyglucose accumulations.J Nucl Med,1996,37:441.
  • 5Shreve PD,Anzai Y,Wahl RL.Pitfall in oncologic diagnosis with FDG PET imaging:physiologic and benign variants.Radiographics,1999,19(1):61.
  • 6Paul G,Kluetz BS,Carolyn CM,et al.Combined PET/CT imaging in oncology impact on patient management.Clin Positronimag,2000,3(6):223.
  • 7Inagaki H,Kato T,Tadokoro M,et al.Interactive fusion of threedimensional imagines of upper abdominal CT and FDG PET with no body surface markers.Radiat Med,1999,17:155.
  • 8Uemahan H,Sadato N,Yonekura Y,et al.Coregistration of FDG PET and MRI of the head and neck using normal distribution of FDG.J Nucl Med,1998,39(12):2121.
  • 9Shreve P D,Radiology,1998年,207卷,431页
  • 10Wei B, Chen L, Tian JH, et al. Preoperative diagnostic accuracy and clinical significance of positron emission computed tomography in gastric cancer. Chin J Gastrointest Surg, 2003,6:167-170.卫勃,陈凛,田嘉禾,等.正电子发

共引文献31

同被引文献8

  • 1沈齐,黎海涛,邹彦,阮培刚,汤明.18F-FDG PET/CT显像在头颈部肿瘤的临床应用分析[J].医学信息(医学与计算机应用),2014,0(4):95-95. 被引量:1
  • 2刘生,蒋宁一,梁九根,卢献平,张宏,刘幸光,陈少雄,杨少梅,伦绮云.^(18)F-FDG符合线路显像在头颈部恶性肿瘤诊断中的应用[J].中华核医学杂志,2005,25(2):95-96. 被引量:4
  • 3张永学,黄钢.核医学[M].2版.北京:人民卫生出版社,2010.74.
  • 4Senti A, Bree R, Golding RP, et al. Interobserver variability in chest CT and whole body FDG-PET screening for distant metastases in head and neck cancer patients[J]. Mol Imaging Biol, 2014, 13(2): 385-390.
  • 5Kyzas PA, Evangelou E, Denaxa-Kyza D. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta- analysis[J]. J Natl Cancer Inst , 2008, 100(10):712-720.
  • 6Kostakoglu L, Fardanesh R, Posner M, et al. Early detection of re- current disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neck[J]. Oncol, 2013, 18(10): 1108-1117.
  • 7VanderWalde NA, Fleming M, Weiss J, et al. Treatment of older pa- tients with head and neck cancer: a review[J]. Oncol, 2013, 18(5): 568-578.
  • 8刘刚.^(18)F-FDG PET/CT对头颈部肿瘤的诊断价值[J].中国实用神经疾病杂志,2014,17(1):43-44. 被引量:2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部